Member Info for gixer

Another reason for taking FF
https://academic.oup.com/cardiovascres/advance-article/doi/10.1093/cvr/cvaa288/5940460
Regional and global contributions of air pollution to risk of death from COVID-19

https://www.provexis.com/?news=fruitflow-nutritional-solutions-alleviate-impact-air-pollution
Fruitflow® – Nutritional Solutions to alleviate the impact of Air Pollution

sphinx, If you go back to 2008-9 you will see that Provexis were going to carry out work/trials? on FF and Diabetes. Think it just got dropped though.
" The research team continue to develop further claim areas for our core technology. In 2008 we will progress
our deep vein thrombosis work, with human studies commencing in 2009. We will commence work on
metabolic syndrome and Type-II diabetes claims in 2009."
https://www.provexis.org/wp-content/uploads/2011/12/Annual-Report-and-Accounts-20081.pdf

"The focus for the research and development programme currently and for 2010 is the development of
our current Deep Vein Thrombosis claim area, as well as extending the range of product applications.
In the longer term we will seek to develop the technology for use in the areas of metabolic syndrome
and type-II diabetes."
https://www.provexis.org/wp-content/uploads/2011/12/Interim-Report-20091.pdf

More reason why not to take Aspirin long term.
https://www.seriousreaders.com/blog/aspirin-linked-to-greater-risk-of-macular-degeneration?utm_source=Serious%20Readers%20Ltd&utm_medium=email&utm_campaign=11937574_OctNews06&dm_i=Q25,73V3A,2AAZYQ,SQE9H,1

Reminder of an article from By-Health from June
http://www.souzhiliao.com/index.php?menu=241&id=240

"Platelet aggregation and cardiovascular disease"

"The high incidence and mortality of cardiovascular diseases are closely related to the prevalence of cardiovascular disease risk factors. Traditional risk factors include hyperlipidemia, hypertension, hyperglycemia"

and then goes on to talk about Fruitflow.

I can't take any credit for the latest news but it does suggest, imo, that we are getting close.
Fingers crossed.

Maybe but I also think blood pressure and cholesterol products are high on the list.

"As for the new functions, we have developed products to help maintain the normal blood platelet aggregation and found ways to reduce advanced glycation end products (AGEs)."

All ready for Brexit?
https://www.gov.uk/government/consultations/nutrition-labelling-composition-and-standards-nlcs-legislation-from-1-january-2021/outcome/the-nutrition-amendment-etc-eu-exit-regulations-2020-consultation-response

https://senedd.wales/laid%20documents/gen-ld13552/gen-ld13552-e.pdf

https://www.parliament.scot/angiestest/20201012_Lttr_IN_Min_PHSW_to_Convener.pdf

All include WSTC but don't ask me what it means lol

https://journals.lww.com/anesthesia-analgesia/Abstract/9000/Aspirin_Use_is_Associated_with_Decreased.95423.aspx?fbclid=IwAR3jwB9V41T87QcfIKAj1xtr9iC2NRI6Yt8mbFmJOlVGXUr9mrI3C97EyDs

https://kknews.cc/news/yj5r9lb.html

We all know that By-Health bought the Australian probiotics firm Life-Space group and although i am not suggesting there is a connection it reminded me of this Chinese patent for a "composition with intestinal and cardiovascular regulating function" that includes galactooligosaccharide and water-soluble tomato concentrate as raw materials.
Galactooligosaccharide is a type of Prebiotic.

https://patentscope.wipo.int/search/en/detail.jsf?docId=CN228767168&_cid=P10-KGG6Q7-95208-1

Not seen this combo before but DSM now seem to be offering a tablet with Probiotics and Fruitflow®

https://www.dsm.com/content/dam/dsm/human-nutrition/pdfs/HNH_Pre-Probiotics_Product_Brochure.pdf

We could really be doing with a proper update on blue cap but can't see us getting one anytime soon.

The way I see it is...
If the whole process takes 2-3 years and By-Health did make there first submission in Feb 2019 then we could, in theory, be as little as 4 months away.
This time would be less, if as you say, the first 2 phases are completed before submission.

Hi sphinx, could you explain why you think the submission process is half way through. I am not seeing the connection. Thanks.

Just to add, out of the 27 function claims that have been predefined in China there is some evidence that By-Health is targeting at least 2 of these so far for Fruitflow.
1. Aiding blood pressure reduction
2. Aiding blood lipids reduction

Good, easy to understand information on the approval procedure. thanks.
Also a good reminder of the "huge potential" of the Chinese market.

Unlike yourself I am a bit more optimistic. We know that Blue Cap can take as little as 2 years and that could mean anytime from this coming February although I would expect a slight delay at SAMR due to Covid-19 . Its unlikely we will see any revenue from by-health this financial year that ends 31st of March but it could come quicker than you think.
Yes there could be a spike in the sp when Blue Cap is announced and some holders will use this to get out but having been here since 2009 I am happy to wait and see what value by-health will bring.
What good has research done? I have no idea but strangely i enjoy spending a few minutes in the morning ferreting around for info and products.

So not "billions and billions of shares" then?
I recon (guess) around 62 mill at a slight discount to todays price should see us through most of next year. Anything less than that would be a bonus and an indication that revenues have increased since March. We already know the first quarter revenues from DSM are good.
"Strong start to the 2020/21 financial year for this business, with first quarter revenues substantially ahead of the comparative quarter in 2019/20"
and then there is always the possibility of blue Hat.

Colbaltblue, did you even think about that before posting?
You think there will be minimum 2 billion more shares issued in the next couple of years. That would raise around £10,000,000 + at today's price.
That's one heck of a wage bill increase.

#keepitrealplease